LA City Council Approves Naloxone Distribution Program for South LA Communities

The Los Angeles City Council has unanimously approved plans to move forward with a pilot program that will distribute naloxone, a life-saving opioid reversal medication, throughout South Los Angeles neighborhoods including areas adjacent to Inglewood and Compton. The initiative aims to combat the region’s escalating opioid crisis, which claimed over 3,000 lives across LA County in 2023.

The motion, introduced in February by Ninth and Tenth district council members Curren Price and Heather Hutt, who represent sections of South LA, received unanimous support from council members present at Friday’s meeting. The approval will initiate a report detailing the resources required for program implementation.

For Inglewood and Compton residents, this program could provide critical access to a medication that can prevent fatal overdoses, particularly as fentanyl-related deaths continue to rise dramatically throughout the region. According to the Los Angeles County Department of Public Health, fentanyl-related deaths increased by approximately 1700% between 2016 and 2023, from 109 to 1,970 cases.

“By expanding access to naloxone, we can empower first responders, community members, and individuals to act swiftly and reduce fatalities, especially in poor neighborhoods where the death rate from fentanyl was at least twice as high,” the council motion states.

The City Council plans to fund the program using available resources from a 2021 opioid settlement. Los Angeles is set to receive between $29.6 million and $53.3 million over an 18-year period from two opioid distributors. Approximately 80% of these funds are restricted for future opioid remediation, with the remaining 20% available for opioid-related projects, according to city documents.

Fentanyl, which lawmakers identify as the leading cause of recent overdose cases, is a synthetic opioid that is 50 times more potent than heroin and 100 times stronger than morphine. Its prevalence in street drugs has contributed significantly to the current crisis, often because users are unaware of its presence in substances they consume.

While the pilot program is initially focused on South Los Angeles, successful implementation could lead to expansion into neighboring communities. Inglewood and Compton residents concerned about opioid use in their neighborhoods should watch for announcements about naloxone distribution sites and training opportunities as the program develops.

Naloxone, also known by the brand name Narcan, is administered as a nasal spray and can rapidly reverse the effects of an opioid overdose, potentially saving lives in emergency situations. The medication works by blocking opioid receptors and restoring normal breathing in someone experiencing an overdose.

The City Council’s vote represents a significant step in addressing the opioid crisis that has impacted communities throughout Los Angeles County, including Inglewood and Compton, where residents have witnessed the devastating effects of addiction and overdose in their neighborhoods.

This story draws on information from NECN, the Los Angeles City Council, and the Los Angeles County Department of Public Health.